Buy APIDRA SOLOSTAR (INSULIN GLULISINE) Online

Description

Description: APIDRA SOLOSTAR is an insulin product manufactured by Sanofi. Each package contains 5 prefilled pens, with each pen containing 3 mL of the active substance Insulin Glulisine. Insulin Glulisine is a rapid-acting insulin analog used in the management of diabetes mellitus to control blood sugar levels.

Active Substance:

• Insulin Glulisine: Insulin Glulisine is a synthetic form of insulin that is structurally similar to human insulin. It is designed to have a rapid onset of action, enabling it to quickly lower blood glucose levels after meals.

Manufacturer:

• Sanofi: Sanofi is the pharmaceutical company responsible for manufacturing APIDRA SOLOSTAR. With a focus on healthcare innovation and patient-centric solutions, Sanofi is a leading global pharmaceutical company dedicated to improving the lives of individuals with diabetes and other chronic conditions.

Uses: APIDRA SOLOSTAR (Insulin Glulisine) is primarily prescribed for the following purposes:

1. Diabetes Management: It is used in the treatment of diabetes mellitus to control hyperglycemia (high blood sugar levels). Insulin Glulisine is particularly effective at managing postprandial (after-meal) glucose spikes due to its rapid onset of action.
2. Insulin Therapy: APIDRA SOLOSTAR may be prescribed as part of a comprehensive insulin regimen for individuals with type 1 diabetes or type 2 diabetes who require insulin supplementation to achieve glycemic control.

How to Use: APIDRA SOLOSTAR pens are intended for subcutaneous injection. The dosage and administration instructions may vary depending on individual factors such as age, weight, diet, and insulin sensitivity. The prefilled pens are designed for ease of use and accurate dosing, with clear markings for dose selection.

Storage Conditions: APIDRA SOLOSTAR pens should be stored as per the manufacturer’s instructions, typically in a refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Once in use, the pens can be kept at room temperature (below 86°F or 30°C) for up to 28 days. It is essential to protect the pens from light and heat and to avoid freezing. Unused pens should be discarded after the expiration date printed on the packaging.

Mechanism of Action: Insulin Glulisine mimics the action of endogenous insulin by binding to insulin receptors on target cells, particularly muscle and adipose tissue cells. This promotes glucose uptake and utilization by cells, leading to a decrease in blood glucose levels. Insulin Glulisine has a rapid onset of action, typically within 10-15 minutes after injection, and a shorter duration of action compared to regular human insulin.

Precautions:

• APIDRA SOLOSTAR should be used with caution in individuals with a history of hypoglycemia (low blood sugar), insulin allergy, or diabetic ketoacidosis. Regular monitoring of blood glucose levels and adjustment of insulin dosage may be necessary to avoid hypoglycemia or hyperglycemia.
• Patients should be educated about proper injection technique, rotation of injection sites, and the timing of insulin administration in relation to meals and physical activity.

Contraindications: APIDRA SOLOSTAR (Insulin Glulisine) is contraindicated in individuals with hypersensitivity to insulin glulisine or any component of the formulation. It should not be used during episodes of hypoglycemia or in insulin pumps.

Drug Interactions: Insulin Glulisine may interact with certain medications, including oral antidiabetic agents, beta-blockers, and corticosteroids. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Side Effects: Common side effects of APIDRA SOLOSTAR may include hypoglycemia, injection site reactions (such as redness, swelling, or itching), and weight gain. Other potential side effects include allergic reactions, lipodystrophy (skin thickening or depressions at injection sites), and changes in potassium levels. Severe hypoglycemia or hyperglycemia may occur in some cases.

Patients should consult their healthcare provider for personalized advice and information regarding APIDRA SOLOSTAR (Insulin Glulisine), including its uses, dosage, and potential side effects.